During the past decade, Devers Eye Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Devers Eye Institute" #1 sponsor was "Allergan" with 3 trials, followed by "Legacy Health System" with 3 trials sponsored, "National Eye Institute (NEI)" with 3 trials sponsored, "American-European Congress of Ophthalmic Surgery" with 1 trials sponsored and "Case Western Reserve University" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Devers Eye Institute" #1 collaborator was "Devers Eye Institute" with 2 trials as a collaborator, "Lions VisionGift Research" with 2 trials as a collaborator, "National Eye Institute (NEI)" with 2 trials as a collaborator, "Eye Bank Association of America" with 1 trials as a collaborator and "Fischer Surgical, Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Devers Eye Institute" are "Cataract" (2 trials), "Multiple Sclerosis" (2 trials), "Optic Neuritis" (2 trials), "Presbyopia" (2 trials) and "Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Devers Eye Institute" in a lesser frequency.

Most popular intervention types in "Devers Eye Institute" are "Drug" (10 trials), "Procedure" (3 trials), "Biological" (2 trials), "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methylprednisolone" (2 trials), "Prednisone" (2 trials), "Vehicle" (2 trials), "AGN-190584 Vehicle" (1 trials) and "AGN-190584 ophthalmic solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Devers Eye Institute" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Devers Eye Institute". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Devers Eye Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Devers Eye Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".

Devers Eye Institute has several departments that took part in Clinical trials: "Legacy Cancer Institute Medical Oncology and Day Treatment" - 23 trials, "Comprehensive Cancer Center at Legacy Good Samaritan Hospital & Medical Center" - 7 trials, "Legacy Medical Group - Pulmonary Clinic" - 4 trials